APO Research
Talk to an analyst

APO RESEARCH · REPORT

KI-67 Antibody

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global KI-67 Antibody Industry Growth and Trends Forecast to 2032

19 December 2025100 pages

Choose your research edition.

Industry ResearchKI-67 Antibody Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal KI-67 Antibody Industry Growth and Trends Forecast to 2032100 pages · $3,450 USDMarket StructureGlobal KI-67 Antibody Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal KI-67 Antibody Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal KI-67 Antibody Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

According to APO Research, the global KI-67 Antibody market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for KI-67 Antibody is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for KI-67 Antibody is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for KI-67 Antibody is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global companies in the KI-67 Antibody market include Atlas Antibodies, BD Biosciences, Beckman Coulter, Bio-Rad, FineTest, Leica Biosystems, Miltenyi Biotec, Miltenyi Biotec and NSJ Bioreagents, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global KI-67 Antibody market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The KI-67 Antibody market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global KI-67 Antibody market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to KI-67 Antibody.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading companies in the global KI-67 Antibody market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

KI-67 Antibody Market by Company

Atlas Antibodies

BD Biosciences

Beckman Coulter

Bio-Rad

FineTest

Leica Biosystems

Miltenyi Biotec

Miltenyi Biotec

NSJ Bioreagents

Proteintech

Synaptic

United States Biological

Merck

Thermo Fisher Scientific

KI-67 Antibody Segment by Type

Polyclonal

Monoclonal

KI-67 Antibody Segment by Application

Immunohistochemistry Paraffin

Immunohistochemistry Frozen

Immunofluorescence

Western Blot

Others

KI-67 Antibody Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global KI-67 Antibody market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of KI-67 Antibody and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of KI-67 Antibody.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 5: Detailed analysis of KI-67 Antibody companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.

Chapter 12: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Global KI-67 Antibody Market Size (US$ Million) Comparison by Region: 2021 VS 2025 VS 2032 Table 2. Global KI-67 Antibody Market Size by Region (2021-2026) & (US$ Million) Table 3. Global KI-67 Antibody Market Share by Region (2021-2026) Table 4. Global KI-67 Antibody Market Size by Region (2027-2032) & (US$ Million) Table 5. Global KI-67 Antibody Market Share by Region (2027-2032) Table 6. Global KI-67 Antibody Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global KI-67 Antibody Market Size by Type (2021-2026) & (US$ Million) Table 8. Global KI-67 Antibody Market Size Share by Type (2021-2026) Table 9. Global KI-67 Antibody Market Size Forecasted by Type (2027-2032) & (US$ Million) Table 10. Global KI-67 Antibody Market Size Share Forecasted by Type (2027-2032) Table 11. North America KI-67 Antibody Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 12. North America KI-67 Antibody Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 13. Europe KI-67 Antibody Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 14. Europe KI-67 Antibody Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 15. Asia-Pacific KI-67 Antibody Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 16. Asia-Pacific KI-67 Antibody Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 17. Latin America KI-67 Antibody Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 18. Latin America KI-67 Antibody Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 19. Middle East and Africa KI-67 Antibody Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 20. Middle East and Africa KI-67 Antibody Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 21. Global KI-67 Antibody Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 22. Global KI-67 Antibody Market Size by Application (2021-2026) & (US$ Million) Table 23. Global KI-67 Antibody Market Size Share by Application (2021-2026) Table 24. Global KI-67 Antibody Market Size Forecasted by Application (2027-2032) & (US$ Million) Table 25. Global KI-67 Antibody Market Size Share Forecasted by Application (2027-2032) Table 26. North America KI-67 Antibody Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 27. North America KI-67 Antibody Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 28. Europe KI-67 Antibody Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 29. Europe KI-67 Antibody Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 30. Asia-Pacific KI-67 Antibody Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 31. Asia-Pacific KI-67 Antibody Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 32. Latin America KI-67 Antibody Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 33. Latin America KI-67 Antibody Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 34. Middle East and Africa KI-67 Antibody Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 35. Middle East and Africa KI-67 Antibody Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 36. KI-67 Antibody Industry Trends Table 37. KI-67 Antibody Industry Drivers Table 38. KI-67 Antibody Industry Opportunities and Challenges Table 39. KI-67 Antibody Industry Restraints Table 40. Global KI-67 Antibody Revenue by Company (US$ Million) & (2021-2026) Table 41. Global KI-67 Antibody Revenue Market Share by Company (2021-2026) Table 42. Global KI-67 Antibody Industry Company Ranking, 2024 VS 2025 VS 2026 Table 43. Global KI-67 Antibody Key Company Headquarters & Area Served Table 44. Global KI-67 Antibody Company, Product Type & Application Table 45. Global KI-67 Antibody Company Commercialization Time Table 46. Global Company Market Concentration Ratio (CR5 and HHI) Table 47. Global KI-67 Antibody by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 48. Atlas Antibodies Company Information Table 49. Atlas Antibodies Business Overview Table 50. Atlas Antibodies KI-67 Antibody Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 51. Atlas Antibodies KI-67 Antibody Product Portfolio Table 52. Atlas Antibodies Recent Development Table 53. BD Biosciences Company Information Table 54. BD Biosciences Business Overview Table 55. BD Biosciences KI-67 Antibody Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 56. BD Biosciences KI-67 Antibody Product Portfolio Table 57. BD Biosciences Recent Development Table 58. Beckman Coulter Company Information Table 59. Beckman Coulter Business Overview Table 60. Beckman Coulter KI-67 Antibody Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 61. Beckman Coulter KI-67 Antibody Product Portfolio Table 62. Beckman Coulter Recent Development Table 63. Bio-Rad Company Information Table 64. Bio-Rad Business Overview Table 65. Bio-Rad KI-67 Antibody Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 66. Bio-Rad KI-67 Antibody Product Portfolio Table 67. Bio-Rad Recent Development Table 68. FineTest Company Information Table 69. FineTest Business Overview Table 70. FineTest KI-67 Antibody Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 71. FineTest KI-67 Antibody Product Portfolio Table 72. FineTest Recent Development Table 73. Leica Biosystems Company Information Table 74. Leica Biosystems Business Overview Table 75. Leica Biosystems KI-67 Antibody Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 76. Leica Biosystems KI-67 Antibody Product Portfolio Table 77. Leica Biosystems Recent Development Table 78. Miltenyi Biotec Company Information Table 79. Miltenyi Biotec Business Overview Table 80. Miltenyi Biotec KI-67 Antibody Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 81. Miltenyi Biotec KI-67 Antibody Product Portfolio Table 82. Miltenyi Biotec Recent Development Table 83. Miltenyi Biotec Company Information Table 84. Miltenyi Biotec Business Overview Table 85. Miltenyi Biotec KI-67 Antibody Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 86. Miltenyi Biotec KI-67 Antibody Product Portfolio Table 87. Miltenyi Biotec Recent Development Table 88. NSJ Bioreagents Company Information Table 89. NSJ Bioreagents Business Overview Table 90. NSJ Bioreagents KI-67 Antibody Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 91. NSJ Bioreagents KI-67 Antibody Product Portfolio Table 92. NSJ Bioreagents Recent Development Table 93. Proteintech Company Information Table 94. Proteintech Business Overview Table 95. Proteintech KI-67 Antibody Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 96. Proteintech KI-67 Antibody Product Portfolio Table 97. Proteintech Recent Development Table 98. Synaptic Company Information Table 99. Synaptic Business Overview Table 100. Synaptic KI-67 Antibody Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 101. Synaptic KI-67 Antibody Product Portfolio Table 102. Synaptic Recent Development Table 103. United States Biological Company Information Table 104. United States Biological Business Overview Table 105. United States Biological KI-67 Antibody Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 106. United States Biological KI-67 Antibody Product Portfolio Table 107. United States Biological Recent Development Table 108. Merck Company Information Table 109. Merck Business Overview Table 110. Merck KI-67 Antibody Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 111. Merck KI-67 Antibody Product Portfolio Table 112. Merck Recent Development Table 113. Thermo Fisher Scientific Company Information Table 114. Thermo Fisher Scientific Business Overview Table 115. Thermo Fisher Scientific KI-67 Antibody Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 116. Thermo Fisher Scientific KI-67 Antibody Product Portfolio Table 117. Thermo Fisher Scientific Recent Development Table 118. North America KI-67 Antibody Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 119. North America KI-67 Antibody Market Size by Country (2021-2026) & (US$ Million) Table 120. North America KI-67 Antibody Market Share by Country (2021-2026) Table 121. North America KI-67 Antibody Market Size Forecast by Country (2027-2032) & (US$ Million) Table 122. North America KI-67 Antibody Market Share Forecast by Country (2027-2032) Table 123. Europe KI-67 Antibody Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 124. Europe KI-67 Antibody Market Size by Country (2021-2026) & (US$ Million) Table 125. Europe KI-67 Antibody Market Share by Country (2021-2026) Table 126. Europe KI-67 Antibody Market Size Forecast by Country (2027-2032) & (US$ Million) Table 127. Europe KI-67 Antibody Market Share Forecast by Country (2027-2032) Table 128. Asia-Pacific KI-67 Antibody Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 129. Asia-Pacific KI-67 Antibody Market Size by Country (2021-2026) & (US$ Million) Table 130. Asia-Pacific KI-67 Antibody Market Share by Country (2021-2026) Table 131. Asia-Pacific KI-67 Antibody Market Size Forecast by Country (2027-2032) & (US$ Million) Table 132. Asia-Pacific KI-67 Antibody Market Share Forecast by Country (2027-2032) Table 133. Latin America KI-67 Antibody Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 134. Latin America KI-67 Antibody Market Size by Country (2021-2026) & (US$ Million) Table 135. Latin America KI-67 Antibody Market Share by Country (2021-2026) Table 136. Latin America KI-67 Antibody Market Size Forecast by Country (2027-2032) & (US$ Million) Table 137. Latin America KI-67 Antibody Market Share Forecast by Country (2027-2032) Table 138. Middle East & Africa KI-67 Antibody Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 139. Middle East & Africa KI-67 Antibody Market Size by Country (2021-2026) & (US$ Million) Table 140. Middle East & Africa KI-67 Antibody Market Share by Country (2021-2026) Table 141. Middle East & Africa KI-67 Antibody Market Size Forecast by Country (2027-2032) & (US$ Million) Table 142. Middle East & Africa KI-67 Antibody Market Share Forecast by Country (2027-2032) Table 143. Research Programs/Design for This Report Table 144. Authors List of This Report Table 145. Secondary Sources List of Figures Figure 1.List of Figures Figure 2. KI-67 Antibody Product Image Figure 3. Global KI-67 Antibody Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 4. Global KI-67 Antibody Market Size (2021-2032) & (US$ Million) Figure 5. Global KI-67 Antibody Market Share by Region: 2025 VS 2032 Figure 6. Global KI-67 Antibody Market Share by Region (2021-2032) Figure 7. North America KI-67 Antibody Market Size Growth Rate (2021-2032) & (US$ Million) Figure 8. Europe KI-67 Antibody Market Size Growth Rate (2021-2032) & (US$ Million) Figure 9. Asia-Pacific KI-67 Antibody Market Size Growth Rate (2021-2032) & (US$ Million) Figure 10. Latin America KI-67 Antibody Market Size Growth Rate (2021-2032) & (US$ Million) Figure 11. Middle East & Africa KI-67 Antibody Market Size Growth Rate (2021-2032) & (US$ Million) Figure 12. Polyclonal Image Figure 13. Global Polyclonal Market Size YoY Growth (2021-2032) & (US$ Million) Figure 14. Monoclonal Image Figure 15. Global Monoclonal Market Size YoY Growth (2021-2032) & (US$ Million) Figure 16. Global KI-67 Antibody Market Size Overview by Type (2021-2032) & (US$ Million) Figure 17. Global KI-67 Antibody Market Share by Type 2025 VS 2032 Figure 18. North America KI-67 Antibody Market Size Share by Type (2021-2032) Figure 19. Europe KI-67 Antibody Market Size Share by Type (2021-2032) Figure 20. Asia-Pacific KI-67 Antibody Market Size Share by Type (2021-2032) Figure 21. Latin America KI-67 Antibody Market Size Share by Type (2021-2032) Figure 22. Middle East and Africa KI-67 Antibody Market Size Share by Type (2021-2032) Figure 23. Immunohistochemistry Paraffin Image Figure 24. Global Immunohistochemistry Paraffin Market Size YoY Growth (2021-2032) & (US$ Million) Figure 25. Immunohistochemistry Frozen Image Figure 26. Global Immunohistochemistry Frozen Market Size YoY Growth (2021-2032) & (US$ Million) Figure 27. Immunofluorescence Image Figure 28. Global Immunofluorescence Market Size YoY Growth (2021-2032) & (US$ Million) Figure 29. Western Blot Image Figure 30. Global Western Blot Market Size YoY Growth (2021-2032) & (US$ Million) Figure 31. Others Image Figure 32. Global Others Market Size YoY Growth (2021-2032) & (US$ Million) Figure 33. Global KI-67 Antibody Market Size Overview by Application (2021-2032) & (US$ Million) Figure 34. Global KI-67 Antibody Market Share by Application 2025 VS 2032 Figure 35. North America KI-67 Antibody Market Size Share by Application (2021-2032) Figure 36. Europe KI-67 Antibody Market Size Share by Application (2021-2032) Figure 37. Asia-Pacific KI-67 Antibody Market Size Share by Application (2021-2032) Figure 38. Latin America KI-67 Antibody Market Size Share by Application (2021-2032) Figure 39. Middle East and Africa KI-67 Antibody Market Size Share by Application (2021-2032) Figure 40. Global Top 5 and 10 KI-67 Antibody Players Market Share by Revenue in 2025 Figure 41. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 42. North America KI-67 Antibody Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 43. North America KI-67 Antibody Market Share by Country: 2021 VS 2025 VS 2032 Figure 44. North America KI-67 Antibody Market Share by Country (2021-2032) Figure 45. Europe KI-67 Antibody Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. Europe KI-67 Antibody Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe KI-67 Antibody Market Share by Country (2021-2032) Figure 48. Asia-Pacific KI-67 Antibody Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 49. Asia-Pacific KI-67 Antibody Market Share by Country: 2021 VS 2025 VS 2032 Figure 50. Asia-Pacific KI-67 Antibody Market Share by Country (2021-2032) Figure 51. Latin America KI-67 Antibody Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Latin America KI-67 Antibody Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America KI-67 Antibody Market Share by Country (2021-2032) Figure 54. Middle East & Africa KI-67 Antibody Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 55. Middle East & Africa KI-67 Antibody Market Share by Country: 2021 VS 2025 VS 2032 Figure 56. Middle East & Africa KI-67 Antibody Market Share by Country (2021-2032) Figure 57. Years Considered Figure 58. Research Process Figure 59. Key Executives Interviewed

Scope & coverage.

Types
  • Polyclonal
  • Monoclonal
Applications
  • Immunohistochemistry Paraffin
  • Immunohistochemistry Frozen
  • Immunofluorescence
  • Western Blot
  • Others
Companies covered
  • Atlas Antibodies
  • BD Biosciences
  • Beckman Coulter
  • Bio-Rad
  • FineTest
  • Leica Biosystems
  • Miltenyi Biotec
  • Miltenyi Biotec
  • NSJ Bioreagents
  • Proteintech
  • Synaptic
  • United States Biological
  • Merck
  • Thermo Fisher Scientific

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.3 Global KI-67 Antibody Market Size Overview by Region 2021 VS 2025 VS 2032
  4. 1.4 Global KI-67 Antibody Market Size by Region (2021-2032)
  5. 1.4.1 Global KI-67 Antibody Market Size by Region (2021-2026)
  6. 1.4.2 Global KI-67 Antibody Market Size by Region (2027-2032)
  7. 1.5 Key Regions KI-67 Antibody Market Size (2021-2032)
  8. 1.5.1 North America KI-67 Antibody Market Size Growth Rate (2021-2032)
  9. 1.5.2 Europe KI-67 Antibody Market Size Growth Rate (2021-2032)
  10. 1.5.3 Asia-Pacific KI-67 Antibody Market Size Growth Rate (2021-2032)
  11. 1.5.4 South America KI-67 Antibody Market Size Growth Rate (2021-2032)
  12. 1.5.5 Middle East & Africa KI-67 Antibody Market Size Growth Rate (2021-2032)
2 KI-67 Antibody Market by Type
  1. 2.1 Type Introduction
  2. 2.1.1 Polyclonal
  3. 2.1.2 Monoclonal
  4. 2.2 Global KI-67 Antibody Market Size by Type
  5. 2.2.1 Global KI-67 Antibody Market Size Overview by Type (2021-2032)
  6. 2.2.2 Global KI-67 Antibody Historic Market Size Review by Type (2021-2026)
  7. 2.2.3 Global KI-67 Antibody Market Size Forecasted by Type (2027-2032)
  8. 2.3 Global KI-67 Antibody Market Size by Regions
  9. 2.3.1 North America KI-67 Antibody Market Size Breakdown by Type (2021-2026)
  10. 2.3.2 Europe KI-67 Antibody Market Size Breakdown by Type (2021-2026)
  11. 2.3.3 Asia-Pacific KI-67 Antibody Market Size Breakdown by Type (2021-2026)
  12. 2.3.4 South America KI-67 Antibody Market Size Breakdown by Type (2021-2026)
  13. 2.3.5 Middle East and Africa KI-67 Antibody Market Size Breakdown by Type (2021-2026)
3 KI-67 Antibody Market by Application
  1. 3.1 Type Introduction
  2. 3.1.1 Immunohistochemistry Paraffin
  3. 3.1.2 Immunohistochemistry Frozen
  4. 3.1.3 Immunofluorescence
  5. 3.1.4 Western Blot
  6. 3.1.5 Others
  7. 3.2 Global KI-67 Antibody Market Size by Application
  8. 3.2.1 Global KI-67 Antibody Market Size Overview by Application (2021-2032)
  9. 3.2.2 Global KI-67 Antibody Historic Market Size Review by Application (2021-2026)
  10. 3.2.3 Global KI-67 Antibody Market Size Forecasted by Application (2027-2032)
  11. 3.3 Global KI-67 Antibody Market Size by Regions
  12. 3.3.1 North America KI-67 Antibody Market Size Breakdown by Application (2021-2026)
  13. 3.3.2 Europe KI-67 Antibody Market Size Breakdown by Application (2021-2026)
  14. 3.3.3 Asia-Pacific KI-67 Antibody Market Size Breakdown by Application (2021-2026)
  15. 3.3.4 South America KI-67 Antibody Market Size Breakdown by Application (2021-2026)
  16. 3.3.5 Middle East and Africa KI-67 Antibody Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
  1. 4.1 KI-67 Antibody Industry Trends
  2. 4.2 KI-67 Antibody Industry Drivers
  3. 4.3 KI-67 Antibody Industry Opportunities and Challenges
  4. 4.4 KI-67 Antibody Industry Restraints
5 Competitive Insights by Company
  1. 5.1 Global Top Players by KI-67 Antibody Revenue (2021-2026)
  2. 5.2 Global KI-67 Antibody Industry Company Ranking, 2024 VS 2025 VS 2026
  3. 5.3 Global KI-67 Antibody Key Company Headquarters & Area Served
  4. 5.4 Global KI-67 Antibody Company, Product Type & Application
  5. 5.5 Global KI-67 Antibody Company Commercialization Time
  6. 5.6 Market Competitive Analysis
  7. 5.6.1 Global KI-67 Antibody Market CR5 and HHI
  8. 5.6.2 Global Top 5 and 10 KI-67 Antibody Players Market Share by Revenue in 2025
  9. 5.6.3 2025 KI-67 Antibody Tier 1, Tier 2, and Tier 3
6 Company Profiles
  1. 6.1 Atlas Antibodies
  2. 6.1.1 Atlas Antibodies Company Information
  3. 6.1.2 Atlas Antibodies Business Overview
  4. 6.1.3 Atlas Antibodies KI-67 Antibody Revenue, Global Share and Gross Margin (2021-2026)
  5. 6.1.4 Atlas Antibodies KI-67 Antibody Product Portfolio
  6. 6.1.5 Atlas Antibodies Recent Developments
  7. 6.2 BD Biosciences
  8. 6.2.1 BD Biosciences Company Information
  9. 6.2.2 BD Biosciences Business Overview
  10. 6.2.3 BD Biosciences KI-67 Antibody Revenue, Global Share and Gross Margin (2021-2026)
  11. 6.2.4 BD Biosciences KI-67 Antibody Product Portfolio
  12. 6.2.5 BD Biosciences Recent Developments
  13. 6.3 Beckman Coulter
  14. 6.3.1 Beckman Coulter Company Information
  15. 6.3.2 Beckman Coulter Business Overview
  16. 6.3.3 Beckman Coulter KI-67 Antibody Revenue, Global Share and Gross Margin (2021-2026)
  17. 6.3.4 Beckman Coulter KI-67 Antibody Product Portfolio
  18. 6.3.5 Beckman Coulter Recent Developments
  19. 6.4 Bio-Rad
  20. 6.4.1 Bio-Rad Company Information
  21. 6.4.2 Bio-Rad Business Overview
  22. 6.4.3 Bio-Rad KI-67 Antibody Revenue, Global Share and Gross Margin (2021-2026)
  23. 6.4.4 Bio-Rad KI-67 Antibody Product Portfolio
  24. 6.4.5 Bio-Rad Recent Developments
  25. 6.5 FineTest
  26. 6.5.1 FineTest Company Information
  27. 6.5.2 FineTest Business Overview
  28. 6.5.3 FineTest KI-67 Antibody Revenue, Global Share and Gross Margin (2021-2026)
  29. 6.5.4 FineTest KI-67 Antibody Product Portfolio
  30. 6.5.5 FineTest Recent Developments
  31. 6.6 Leica Biosystems
  32. 6.6.1 Leica Biosystems Company Information
  33. 6.6.2 Leica Biosystems Business Overview
  34. 6.6.3 Leica Biosystems KI-67 Antibody Revenue, Global Share and Gross Margin (2021-2026)
  35. 6.6.4 Leica Biosystems KI-67 Antibody Product Portfolio
  36. 6.6.5 Leica Biosystems Recent Developments
  37. 6.7 Miltenyi Biotec
  38. 6.7.1 Miltenyi Biotec Company Information
  39. 6.7.2 Miltenyi Biotec Business Overview
  40. 6.7.3 Miltenyi Biotec KI-67 Antibody Revenue, Global Share and Gross Margin (2021-2026)
  41. 6.7.4 Miltenyi Biotec KI-67 Antibody Product Portfolio
  42. 6.7.5 Miltenyi Biotec Recent Developments
  43. 6.8 Miltenyi Biotec
  44. 6.8.1 Miltenyi Biotec Company Information
  45. 6.8.2 Miltenyi Biotec Business Overview
  46. 6.8.3 Miltenyi Biotec KI-67 Antibody Revenue, Global Share and Gross Margin (2021-2026)
  47. 6.8.4 Miltenyi Biotec KI-67 Antibody Product Portfolio
  48. 6.8.5 Miltenyi Biotec Recent Developments
  49. 6.9 NSJ Bioreagents
  50. 6.9.1 NSJ Bioreagents Company Information
  51. 6.9.2 NSJ Bioreagents Business Overview
  52. 6.9.3 NSJ Bioreagents KI-67 Antibody Revenue, Global Share and Gross Margin (2021-2026)
  53. 6.9.4 NSJ Bioreagents KI-67 Antibody Product Portfolio
  54. 6.9.5 NSJ Bioreagents Recent Developments
  55. 6.10 Proteintech
  56. 6.10.1 Proteintech Company Information
  57. 6.10.2 Proteintech Business Overview
  58. 6.10.3 Proteintech KI-67 Antibody Revenue, Global Share and Gross Margin (2021-2026)
  59. 6.10.4 Proteintech KI-67 Antibody Product Portfolio
  60. 6.10.5 Proteintech Recent Developments
  61. 6.11 Synaptic
  62. 6.11.1 Synaptic Company Information
  63. 6.11.2 Synaptic Business Overview
  64. 6.11.3 Synaptic KI-67 Antibody Revenue, Global Share and Gross Margin (2021-2026)
  65. 6.11.4 Synaptic KI-67 Antibody Product Portfolio
  66. 6.11.5 Synaptic Recent Developments
  67. 6.12 United States Biological
  68. 6.12.1 United States Biological Company Information
  69. 6.12.2 United States Biological Business Overview
  70. 6.12.3 United States Biological KI-67 Antibody Revenue, Global Share and Gross Margin (2021-2026)
  71. 6.12.4 United States Biological KI-67 Antibody Product Portfolio
  72. 6.12.5 United States Biological Recent Developments
  73. 6.13 Merck
  74. 6.13.1 Merck Company Information
  75. 6.13.2 Merck Business Overview
  76. 6.13.3 Merck KI-67 Antibody Revenue, Global Share and Gross Margin (2021-2026)
  77. 6.13.4 Merck KI-67 Antibody Product Portfolio
  78. 6.13.5 Merck Recent Developments
  79. 6.14 Thermo Fisher Scientific
  80. 6.14.1 Thermo Fisher Scientific Company Information
  81. 6.14.2 Thermo Fisher Scientific Business Overview
  82. 6.14.3 Thermo Fisher Scientific KI-67 Antibody Revenue, Global Share and Gross Margin (2021-2026)
  83. 6.14.4 Thermo Fisher Scientific KI-67 Antibody Product Portfolio
  84. 6.14.5 Thermo Fisher Scientific Recent Developments
7 North America
  1. 7.1 North America KI-67 Antibody Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 7.2 North America KI-67 Antibody Market Size by Country (2021-2026)
  3. 7.3 North America KI-67 Antibody Market Size Forecast by Country (2027-2032)
8 Europe
  1. 8.1 Europe KI-67 Antibody Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 8.2 Europe KI-67 Antibody Market Size by Country (2021-2026)
  3. 8.3 Europe KI-67 Antibody Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
  1. 9.1 Asia-Pacific KI-67 Antibody Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 9.2 Asia-Pacific KI-67 Antibody Market Size by Country (2021-2026)
  3. 9.3 Asia-Pacific KI-67 Antibody Market Size Forecast by Country (2027-2032)
10 South America
  1. 10.1 South America KI-67 Antibody Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 10.2 South America KI-67 Antibody Market Size by Country (2021-2026)
  3. 10.3 South America KI-67 Antibody Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
  1. 11.1 Middle East & Africa KI-67 Antibody Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 11.2 Middle East & Africa KI-67 Antibody Market Size by Country (2021-2026)
  3. 11.3 Middle East & Africa KI-67 Antibody Market Size Forecast by Country (2027-2032)
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst